1. Pink Sheet
  2. >>Regulatory Trackers
  3. >>US FDA Performance Tracker

Trevena's Intravenous Opioid Will Face Difficult US FDA Advisory Committee

 
• By Brenda Sandburg

Oliceridine is not superior to morphine, has abuse potential similar to other mu opioid agonists, FDA concludes; also endpoint Trevena used to evaluate respiratory safety was inadequate, FDA says.

An ampoule with opioid. In the background there are still ampoules

Trevena Inc.'s intravenous opioid Olinvo (oliceridine) will need to overcome the US FDA's concerns about the endpoint used to compare its respiratory safety to that of morphine during the product's upcoming advisory committee review.

Like many of the other advisory committee meetings that have considered opioids recently, the session looks like it will be...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from US FDA Performance Tracker

More from Regulatory Trackers

US FDA’s CRL Release More Incremental Than ‘Radical’ Transparency

 
• By Bridget Silverman

The transparency initiative collects CRLs already made public in approval packages on its drugs@fda site to post on the openFDA public portal.

America Next: Most Novel Agents With July Goal Dates Have Been Approved Overseas

 
• By Bridget Silverman

The US FDA will not be in its usual position as the first regulator to approve novel drugs, with only one of the six novel candidates on the July user fee calendar seeking its first approval worldwide in the US

EU CHMP Opinions And MAA Updates

 
• By Neena Brizmohun

This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the EU, and updates on EU marketing authorization changes recommended by the CHMP.